Sacide Altınöz

Sacide Altınöz

Auto-generated profile, based on publicly available information

Sacide Altınöz

BAŞKENT ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ, ECZACILIK TEMEL BİLİMLERİ BÖLÜMÜ, ANALİTİK KİMYA ANABİLİM DALI

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Dissolution Technologies
Verified
Journal Article
Open access
MÇMustafa Çelebier
Mustafa Çelebier
MKMustafa Sinan Kaynak
Mustafa Sinan Kaynak
SASacide Altinoz
Sacide Altinoz
SSSelma Sahin
Selma Sahin

1 December 2024 in Hacettepe University Journal of the Faculty of Pharmacy
Verified
Journal Article
Closed access
SÖSevinç Ayla Özsar
Sevinç Ayla Özsar
SASacide Altınöz
Sacide Altınöz
High Performance Liquid Chromatographic method was developed and validated for the analysis of a pharmaceutical preparation (TRIPLIXAM®) consist of Perindopril (PRN), İndapamide (IND) and Amlodipine (AML) which are used for the control of hypertension in patients with high blood pressure. In this developed HPLC method, ACE 5 C18 analytical column (12.5 x 4.6 mm) was used for the analysis of PRN, IND and AML. Acetonitril and 50 mM phosphate buffer mixture (40:60 v/v) was used as mobile phase. Measurements were obtained at 215 nm wavelength using UV detector. Retention times of PRN, AML and IND were 2.22, 3.48 and 5.05 min. respectively, at selected chromatographical conditions. The developed HPLC method was validated in terms of stability, accuracy, sensitivity, linearity, precision, specificity, ruggedness and robustness in accordance with ICH analytical method. Linear calibration curves were obtained in the range of 1.0-25.0 ppm; 1.0-8.0 ppm and 1.0-40.0 ppm for PRN, IND and AML, respectively. In this HPLC method the limit of dedection values (LOD) for PRN, IND and AML were 0.25 ppm, 0.10 ppm and 0.15 ppm while limit of quantification values (LOQ) were 0.50 ppm, 0.25 ppm and 0.40 ppm, respectively.

5 December 2023 in Hacettepe University Journal of the Faculty of Pharmacy
Verified
Journal Article
Closed access
DEDuygu Eneş
Duygu Eneş
MÇMustafa Çelebier
Mustafa Çelebier
DDDerya Dikmen
Derya Dikmen
SASacide Altinöz
Sacide Altinöz
Curcumin is a natural polyphenol product isolated from the rhizome of the Curcuma longa plant and is the most active ingredient of this plant. Curcumin has hepatoprotective, nephroprotective, thrombosis-suppressing, cardioprotective, antidiabetic and antirheumatic effects. This study aimed to develop an HPLC method for analyzing curcumin in its commercial capsules. Supelco Discovery 5 µm C18 Column (4.6mm x 5.0 µm) was used for chromatographic separation. The mobile phase was acetonitrile (ACN), 20 mM phosphate buffer, pH 6 (40:60 v/v), the flow rate was 1.5 mL min-1, and U.V. detection was 262 nm. The retention time was about 6.13 minutes for curcumin. The developed method was validated according to the ICH guidelines. The method was selective under experimental conditions. It was linear within the range of 0.05 - 50.0 μg mL-1. The intraday and inter-day studies showed that the RSD% was lower than 2.0 for intraday and 2.0 for interday, and the Bias% was lower than 2.0 for intraday, and 2.0 for interday. The method could be successfully used in curcumin-loaded commercial capsules' quality control.

1 March 2021 in Combinatorial Chemistry & High Throughput Screening
Verified
Journal Article
Closed access
PDF file
MÇMustafa Çelebier
Mustafa Çelebier
ADAysegul Dogan
Aysegul Dogan
ISIncilay Suslu
Incilay Suslu
SASacide Altınöz
Sacide Altınöz
Background: Bronchial asthma and chronic obstructive pulmonary disease (COPD) are among the most common chronic diseases. Roflumilast is a novel, potent, selective, and long-acting phosphodiesterase 4 (PDE-4) inhibitor for the treatment of bronchial asthma and COPD. It has anti-inflammatory effects and it has been shown to reduce exacerbations and improve pulmonary function in patients with COPD. Although there have been some other analytical methodologies reported for the determination of roflumilast in pharmaceutical dosage forms, there has not yet been any electrochemical methodology proposed for determination of this unique active pharmaceutical ingredient in its dosage forms. Objective: The aim of this study was to develop an easily applied, selective, sensitive, accurate, and precise square-wave stripping voltammetric (SWSV) method for the determination of roflumilast in its pharmaceutical dosage forms. In addition, the electrochemical behavior of roflumilast was investigated. Methods: The proposed method was based on electrochemical reduction of roflumilast at a hanging mercury drop electrode (HMDE) in 0.1 M K2HPO4 and 0.1 M Na2B4O7 (1:1, v/v) buffer at pH 5.0. Two reduction peaks were observed at -1150 mV and -1260 mV with 30 s of accumulation time and -850 mV of accumulation potential time versus Ag/AgCl reference electrode. Results: The highest peak current values with the best peak definition were observed at a frequency of 50 Hz, scan increment of 5 mV, and pulse amplitude 25 mV. The proposed method was validated by evaluating validation parameters such as linearity, sensitivity, repeatability, accuracy, precision, selectivity, recovery, robustness, and ruggedness. A good linear correlation (r=0.9948) was obtained between the electrochemical response of roflumilast and its concentration in the range of 0.74-3.05 µg mL-1 under the optimum conditions. The obtained accuracy results were between 2.04% and -2.04% while the relative standard deviation of the results was at least 2.78% for intra-day and inter-day studies. Mean recovery for the real applications was 100.63% ± 0.52%. The electrochemical behavior of roflumilast was investigated by cyclic voltammetry. The cyclic voltammogram of roflumilast exhibited two peaks and the reduction reaction was reversible. Conclusion: This developed and validated SWSV method was applied successfully for the determination of roflumilast in tablet dosage form (Daxas) to assess active roflumilast content. Since high-performance liquid chromatography is a dominant technique in industry for quality control of active pharmaceutical ingredients, the finding in the present study demonstrated that square-wave stripping voltammetry could be easily utilized in routine applications to determine roflumilast content in its dosage forms.

28 June 2025 in Journal of Research in Pharmacy
Verified
Journal Article
Open access
PDF file
DEDuygu Eneş
Duygu Eneş
BFBilge Başak FİDAN
Bilge Başak FİDAN
OKOzan Kaplan
Ozan Kaplan
ADAyşegül Doğan
Ayşegül Doğan
SASacide Altınöz
Sacide Altınöz
MKMustafa Sinan Kaynak
Mustafa Sinan Kaynak
The usage of dexamethasone for pediatric applications is a well-known issue. In the present study, we developed an oral dexamethasone solution formulation especially aimed for dose-dependent personalized therapies and having excipients known as not harmful to be safely used in pediatrics. The aim of this study was to prepare an easy-of- use pediatric oral solution of dexamethasone and develop an UV/VIS Spectrophotometric method for the evaluation of the stability and quality control of the developed formulation. The primary source of dexamethasone for preparation of the oral pediatric solution was the dexamethasone one-time injectable solutions. This allowed the formulation to be easily prepared in basic laboratory conditions. Dexamethasone content and stability of the formulation were ensured by quantification using the developed UV/VIS Spectrophotometric method validated based on ICH Q2 (R1) guidelines. Simple, fast, reliable, and validated spectrophotometric analysis of dexamethasone was carried out at 269 nm wavelength and the method was linear in a range of 1.00 to 50.00 μg mL–1.The developed formulation was stable at 4 °C at least for three weeks when protected from daylight. The other stability conditions (ambient temperature and -20 °C) were also evaluated for the assays. Although the methodology used in this study contains simple processes which can be easily adapted to basic laboratory conditions, the results were satisfactory to prepare an ease-of-use pediatric oral solution of dexamethasone for personalized medicine. The validated UV/VIS Spectrophotometric method was selective for the formulation and easily applied for the quality control and stability studies of the samples. Such formulations could be helpful for health professionals in managing real-life corticosteroid treatment application problems especially for pediatrics in hospital pharmacy.